Tag: Vaccines
Racial/Ethnic Minorities Underrepresented in Vaccine Trials
In adult trials, White patients and women are overrepresented; White patients account for 77.9 percent of participants
COVID-19 Vaccine Makers Planning for Variants
Pfizer, BioNTech in discussions with regulators about testing an adapted version of their vaccine
Pfizer, Moderna Tell Congress a Big Jump in Vaccine Supply Is Coming
By end of March, Pfizer and Moderna expect to have delivered a total of 220 million vaccine doses to the U.S. government
Nationwide Study Shows BNT162b2 mRNA Vaccine Is Effective
In mass vaccination setting, vaccine is effective for symptomatic COVID-19, hospitalization, severe disease, death
FDA Review Reveals J&J COVID-19 Vaccine Safe, Effective
Advisory panel set to meet Friday to recommend whether the agency should authorize the shot for emergency use
Children Given Flu Shot Less Likely to Have Symptomatic COVID-19
Odds also lower for having severe disease for patients vaccinated for influenza, pneumococcal disease
FDA: New Variants Mean COVID-19 Vaccines, Tests May Need Tweaking
Agency offers recommendations for companies seeking to modify already-approved vaccines, medicines, and tests so they can remain effective
CDC Report Shows No Evidence of Unexpected Adverse Events With COVID-19 Vaccines
Findings from the first month show no unexpected adverse events, with 6,994 adverse events and >90 percent classified as nonserious
COVID-19 Vaccine Efficacy Higher With Three-Month Interval Between Doses
For ChAdOx1 nCoV-19 Oxford vaccine, three-month interval results in higher efficacy than six-week interval
All British Adults Should Have First COVID-19 Shot by July 31: Government
Announcement made as government prepares a 'cautious' reopening plan
